OIS Podcast Ep

Поділитися
Вставка
  • Опубліковано 6 чер 2024
  • In our latest episode, host Dr. Rob Rothman interviews Greg Kunst, CEO of Aurion Biotech, to delve into the forefront of cell therapy for corneal disease. Join us to discover:
    🔹Greg's journey from pivotal roles at Alcon and Glaukos to leading Aurion Biotech
    🔹The innovative allogenic cell therapy technology developed by Aurion
    🔹How this technology addresses the global shortage of corneal tissue
    🔹Insights into the challenges and breakthroughs in scaling production and securing market approval
    🔹Future applications of cell therapy in ophthalmology beyond corneal endothelial disease
    Don't miss this fascinating conversation on the future of medical innovation in ophthalmology! Listen to the episode and subscribe to the OIS Podcast for more updates on the latest trends in eye care and medical technology.
    Website:
    ois.net
    FOLLOW Ophthalmology Innovation Source On Social Media:
    ► LinkedIn: / ois-net
    ► Twitter: / oistweets
    JOIN Our Group For Ophthalmology Innovation & Investment On LinkedIn
    / 2189664
    SUBSCRIBE To Our Weekly OIS Newsletter
    bit.ly/2yFOXUt
    VIEW Our Past Ophthalmology Event Conferences:
    ois.net/past-events
    REGISTER For Our Next Meeting:
    ois.net/ois-events/
    #OIS #Ophthalmology #Healthcare #Ophthalmic #Medicalinnovation #Retina #Eyediseases
    _________________________________________________________________
    About OIS
    Ophthalmology Innovation Summit (OIS) facilitates meaningful interactions and the exchange of information between clinical, capital, and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.
    Since 2009, the Ophthalmology Innovation Summit programs are independently produced conferences presented annually by Healthegy, Inc.
  • Наука та технологія

КОМЕНТАРІ • 1

  • @masudpervez1341
    @masudpervez1341 Місяць тому

    Thank you for this fascinating episode on revolutionizing eye care with Greg Kunst! The insights into Aurion Biotech's allogenic cell therapy for corneal disease are truly groundbreaking. Greg's journey and the innovative solutions addressing the global corneal tissue shortage are inspiring. The discussion on challenges, breakthroughs, and future applications in ophthalmology is enlightening. Excited to see the future of medical innovation in eye care! Subscribed for more updates.